These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36523602)

  • 1. Identification of glycolysis genes signature for predicting prognosis in malignant pleural mesothelioma by bioinformatics and machine learning.
    Xiao Y; Huang W; Zhang L; Wang H
    Front Endocrinol (Lausanne); 2022; 13():1056152. PubMed ID: 36523602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker.
    Lin P; Zhao Y; Li X; Liang Z
    Comb Chem High Throughput Screen; 2022; 25(9):1498-1506. PubMed ID: 34238152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
    Zhang X; Yang L; Chen W; Kong M
    Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma.
    Huang W; Xiao Y; Wang H; Chen G; Li K
    Front Endocrinol (Lausanne); 2022; 13():1047433. PubMed ID: 36387908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic significance and immune cell infiltration analysis of differentially expressed genes in malignant pleural mesothelioma].
    Wang N; Zhao QN; Yuan Q; Zhu BL; Wu W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Sep; 41(9):641-647. PubMed ID: 37805421
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression and clinical significance of COL1A1 and COL1A2 genes in malignant pleural mesothelioma tissues].
    Li B; Pu YQ; Li ZL; Zhao Y; Zi JJ; Xiong W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Jul; 40(7):487-494. PubMed ID: 35915937
    [No Abstract]   [Full Text] [Related]  

  • 7. [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma].
    Mei W; Wang XM; Liu RA; Xiong W; Zhang YP
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Apr; 42(4):258-267. PubMed ID: 38677988
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients.
    Bai Y; Wang X; Hou J; Geng L; Liang X; Ruan Z; Guo H; Nan K; Jiang L
    Front Genet; 2020; 11():899. PubMed ID: 32849853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
    Zauderer MG; Martin A; Egger J; Rizvi H; Offin M; Rimner A; Adusumilli PS; Rusch VW; Kris MG; Sauter JL; Ladanyi M; Shen R
    Lancet Digit Health; 2021 Sep; 3(9):e565-e576. PubMed ID: 34332931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical significance of SETD2 in maligant pleural mesothelioma].
    Yu M; Yu M; Zhu LJ; Yuan XY; Zhang X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):91-98. PubMed ID: 33691361
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods.
    Liu X; Qian K; Lu G; Chen P; Zhang Y
    BMC Med Genomics; 2021 Apr; 14(1):104. PubMed ID: 33849532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma.
    Zhou JG; Zhong H; Zhang J; Jin SH; Roudi R; Ma H
    Front Oncol; 2019; 9():78. PubMed ID: 30828567
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expression of CD24 gene in human malignant pleural mesothelioma and its relationship with prognosis].
    Li B; Zhou CX; Pu YQ; Qiu L; Mei W; Xiong W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Mar; 41(3):168-176. PubMed ID: 37006141
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated Bioinformatics and Machine Learning Analysis Identify ACADL as a Potent Biomarker of Reactive Mesothelial Cells.
    Yin Y; Cui Q; Zhao J; Wu Q; Sun Q; Wang HQ; Yang W
    Am J Pathol; 2024 Jul; 194(7):1294-1305. PubMed ID: 38657836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration.
    Shi J; Peng B; Zhou X; Wang C; Xu R; Lu T; Chang X; Shen Z; Wang K; Xu C; Zhang L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12089-12102. PubMed ID: 37421452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Transcriptomic Analysis of Wound-Healing-Associated Genes in Malignant Pleural Mesothelioma.
    Rouka E; Beltsios E; Goundaroulis D; Vavougios GD; Solenov EI; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31212858
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma.
    Jiang Y; Zhang C; Chen Y; Zhao S; He Y; He J
    Cancer Med; 2023 Feb; 12(4):4895-4906. PubMed ID: 36031798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition.
    de Reyniès A; Jaurand MC; Renier A; Couchy G; Hysi I; Elarouci N; Galateau-Sallé F; Copin MC; Hofman P; Cazes A; Andujar P; Imbeaud S; Petel F; Pairon JC; Le Pimpec-Barthes F; Zucman-Rossi J; Jean D
    Clin Cancer Res; 2014 Mar; 20(5):1323-34. PubMed ID: 24443521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.